Compounds > chromium
Page last updated: 2024-08-22

chromium and Cancer of Intestines

chromium has been researched along with Cancer of Intestines in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's1 (6.67)18.2507
2000's1 (6.67)29.6817
2010's9 (60.00)24.3611
2020's3 (20.00)2.80

Authors

AuthorsStudies
Harris, MA; Kirman, C; Thompson, CM1
Bhat, VS; Cohen, SM; Cullen, JM; Gordon, EB; Harris, MA; Proctor, DM; Thompson, CM; Wood, CE1
Chappell, GA; Thompson, CM; Wikoff, DS1
Harris, MA; Haws, LC; Proctor, DM; Suh, M; Thompson, CM1
Harris, MA; Harvey, SE; Haws, LC; Hays, SM; Kirman, CR; Proctor, DM; Rager, JE; Suh, M; Thompson, CM1
Harris, MA; Haws, LC; Kirman, CR; Proctor, DM; Suh, M; Thompson, CM1
Harris, MA; Haws, LC; Hays, SM; Hixon, JG; Kirman, CR; Proctor, DM; Suh, M; Thompson, CM1
Haney, J1
Stern, AH1
Gatto, NM; Harris, MA; Haws, LC; Proctor, DM; Thompson, CM1
Harris, MA; Proctor, DM; Suh, M; Thompson, CM1
Forgacs, AL; Kim, S; Kopec, AK; Thompson, CM; Zacharewski, TR1
Charles, MJ; Lakshmi, PV; Raju, GJ; Reddy, BS; Reddy, SB; Reddy, TS; Vijayan, V1
Gunnarsdottir, H; Kiilunen, M; Rafnsson, V1
Anghileri, LJ; Dogàn, EB1

Reviews

4 review(s) available for chromium and Cancer of Intestines

ArticleYear
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
    Critical reviews in toxicology, 2020, Volume: 50, Issue:8

    Topics: Adverse Outcome Pathways; Animals; Captan; Chromium; Duodenum; Fungicides, Industrial; Humans; Hyperplasia; Intestinal Neoplasms; Mice; Phthalimides; Risk Assessment

2020
Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents.
    Mutation research. Genetic toxicology and environmental mutagenesis, 2017, Volume: 823

    Topics: Animals; Chromium; Disease Models, Animal; DNA Damage; Gene Expression Profiling; Intestinal Neoplasms; Mice; Mutagenesis; Mutagenicity Tests; Mutagens; Reproducibility of Results; Risk Assessment; Toxicokinetics; United States; United States Environmental Protection Agency

2017
Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.
    Critical reviews in toxicology, 2013, Volume: 43, Issue:3

    Topics: Animals; Chromium; Drinking Water; Humans; Intestinal Neoplasms; Intestine, Small; Mice; Rats

2013
Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 119, Issue:1

    Topics: Administration, Oral; Animals; Carcinogens, Environmental; Chromium; Guidelines as Topic; Humans; Intestinal Neoplasms; Mice; Models, Theoretical; Research Design; Risk Assessment; United States; United States Environmental Protection Agency

2011

Other Studies

11 other study(ies) available for chromium and Cancer of Intestines

ArticleYear
Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data.
    Regulatory toxicology and pharmacology : RTP, 2023, Volume: 145

    Topics: Animals; Chromium; Intestinal Neoplasms; Mice; Mouth Neoplasms; Mutagenesis; Mutagens

2023
Assessment of Mechanistic Data for Hexavalent Chromium-Induced Rodent Intestinal Cancer Using the Key Characteristics of Carcinogens.
    Toxicological sciences : an official journal of the Society of Toxicology, 2021, 02-26, Volume: 180, Issue:1

    Topics: Animals; Carcinogens; Carcinogens, Environmental; Chromium; Humans; Intestinal Neoplasms; Mice; Risk Assessment; Rodentia

2021
Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.
    Journal of applied toxicology : JAT, 2018, Volume: 38, Issue:3

    Topics: Administration, Oral; Animals; Biological Assay; Calibration; Carcinogenicity Tests; Chromium; Dose-Response Relationship, Drug; Environmental Pollutants; Female; Humans; Intestinal Neoplasms; Male; Mice; Models, Biological; No-Observed-Adverse-Effect Level; Rats; Reference Standards; Risk Assessment; Species Specificity; United States; United States Environmental Protection Agency

2018
A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.
    Journal of applied toxicology : JAT, 2014, Volume: 34, Issue:5

    Topics: Animals; Carcinogenicity Tests; Chromium; Dose-Response Relationship, Drug; Drinking Water; Female; Humans; Hyperplasia; Intestinal Neoplasms; Male; Mice; Models, Biological; No-Observed-Adverse-Effect Level; Reference Standards; Sex Factors; Toxicity Tests, Chronic; United States; United States Environmental Protection Agency; Water Pollutants, Chemical

2014
Implications of dose-dependent target tissue absorption for linear and non-linear/threshold approaches in development of a cancer-based oral toxicity factor for hexavalent chromium.
    Regulatory toxicology and pharmacology : RTP, 2015, Volume: 72, Issue:2

    Topics: Administration, Oral; Animals; Carcinogens; Chromium; Dose-Response Relationship, Drug; Humans; Intestinal Absorption; Intestinal Neoplasms; Mice; Reference Values; Risk Assessment

2015
A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure.
    Environmental research, 2010, Volume: 110, Issue:8

    Topics: Administration, Oral; Animals; Carcinogenicity Tests; Carcinogens; Chromium; Environmental Exposure; Female; Humans; Intestinal Neoplasms; Male; Mice; Rats; Rats, Inbred F344; Risk Assessment

2010
A response to "A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure".
    Environmental research, 2011, Volume: 111, Issue:3

    Topics: Administration, Oral; Animals; Carcinogens, Environmental; Chromium; Intestinal Neoplasms; Mice; Rats

2011
Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.
    Toxicology and applied pharmacology, 2012, Jul-15, Volume: 262, Issue:2

    Topics: Animals; Carcinogens, Environmental; Chromium; Dose-Response Relationship, Drug; Female; Intestinal Neoplasms; Intestine, Small; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA; Species Specificity

2012
Trace elemental analysis of cancer-afflicted intestine by PIXE technique.
    Biological trace element research, 2004,Winter, Volume: 102, Issue:1-3

    Topics: Chromium; Humans; Intestinal Neoplasms; Intestines; Iron; Nickel; Reference Values; Spectrometry, X-Ray Emission; Trace Elements; Zinc

2004
Risk of lung cancer among masons in Iceland.
    Occupational and environmental medicine, 1997, Volume: 54, Issue:3

    Topics: Aged; Carcinogens, Environmental; Chromium; Cohort Studies; Construction Materials; Humans; Iceland; Incidence; Intestinal Neoplasms; Lung Neoplasms; Male; Occupational Diseases; Registries; Retrospective Studies; Risk Factors

1997
Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells: use of a new colloidal 32P-chromic phosphate.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1968, Volume: 9, Issue:11

    Topics: Abdominal Neoplasms; Acids; Adnexal Diseases; Animals; Chromium; Colloids; Female; Injections, Intraperitoneal; Intestinal Neoplasms; Male; Neoplasm Metastasis; Neoplasm Transplantation; Pancreatic Neoplasms; Peritoneal Neoplasms; Phosphates; Phosphorus Isotopes; Rats; Sarcoma, Yoshida

1968